Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Ripasudil hydrochloride hydrate by Kowa for Corneal Edema: Likelihood of Approval
Ripasudil hydrochloride hydrate is under clinical development by Kowa and currently in Phase III for Corneal Edema. According to GlobalData,...
Ripasudil hydrochloride hydrate by Kowa for Retinopathy Of Prematurity: Likelihood of Approval
Ripasudil hydrochloride hydrate is under clinical development by Kowa and currently in Phase II for Retinopathy Of Prematurity. According to...
Ripasudil hydrochloride hydrate by Kowa for Fuchs Endothelial Corneal Dystrophy (FECD): Likelihood of Approval
Ripasudil hydrochloride hydrate is under clinical development by Kowa and currently in Phase III for Fuchs Endothelial Corneal Dystrophy (FECD)....